Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

NCT01234545 · clinicaltrials.gov ↗

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A
Haemophilia B

Interventions

DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S